Primary Site >> Colorectal Cancer
Gene >> NRP1
| 1. | |||||||||||
| Journal: | Am J Pathol. 2004 Jun;164(6):2139-51. | ||||||||||
| Title: | Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. | ||||||||||
| Author: | Parikh, Alexander A|Fan, Fan|Liu, Wen Biao|Ahmad, Syed A|Stoeltzing, Oliver|Reinmuth, Niels|Bielenberg, Diane|Bucana, Corazon D|Klagsbrun, Michael|Ellis, Lee M | ||||||||||
| PMID: | 15161648 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncol Rep. 2006 Feb;15(2):369-73. | ||||||||||
| Title: | The preserved expression of neuropilin (NRP) 1 contributes to a better prognosis in colon cancer. | ||||||||||
| Author: | Kamiya, Takashi|Kawakami, Tsutomu|Abe, Yoshiyuki|Nishi, Masatake|Onoda, Noboru|Miyazaki, Noriyuki|Oida, Yasuhisa|Yamazaki, Hitoshi|Ueyama, Yoshito|Nakamura, Masato | ||||||||||
| PMID: | 16391856 | ||||||||||
| 3. | |||||||||||
| Journal: | Postepy Hig Med Dosw (Online). 2006;60:453-70. | ||||||||||
| Title: | [Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer]. | ||||||||||
| Author: | Widel, Maciej S|Widel, Maria | ||||||||||
| PMID: | 17013365 | ||||||||||
| 4. | |||||||||||
| Journal: | Pharmacogenomics. 2007 Dec;8(12):1705-13. | ||||||||||
| Title: | Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients. | ||||||||||
| Author: | Azuma, Mizutomo|Shi, Michael|Danenberg, Kathleen D|Gardner, Humphrey|Barrett, Carl|Jacques, Christian J|Sherod, Andrew|Iqbal, Syma|El-Khoueiry, Anthony|Yang, Dongyun|Zhang, Wu|Danenberg, Peter V|Lenz, Heinz-Josef | ||||||||||
| PMID: | 18086000 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncol Rep. 2009 May;21(5):1161-8. | ||||||||||
| Title: | No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2. | ||||||||||
| Author: | Quante, Michael|Raskopf, Esther|Stahl, Sebastian|Vogt, Annabelle|Sauerbruch, Tilman|Schmitz, Volker | ||||||||||
| PMID: | 19360289 | ||||||||||
| 6. | |||||||||||
| Journal: | Cancer Res. 2009 Oct 15;69(20):7905-10. | ||||||||||
| Title: | Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. | ||||||||||
| Author: | Xu, Lei|Duda, Dan G|di Tomaso, Emmanuelle|Ancukiewicz, Marek|Chung, Daniel C|Lauwers, Gregory Y|Samuel, Rekha|Shellito, Paul|Czito, Brian G|Lin, Pei-Chun|Poleski, Martin|Bentley, Rex|Clark, Jeffrey W|Willett, Christopher G|Jain, Rakesh K | ||||||||||
| PMID: | 19826039 | ||||||||||
| 7. | |||||||||||
| Journal: | J Clin Invest. 2010 Aug;120(8):2658-60. | ||||||||||
| Title: | Semaphorin 3E, an exception to the rule. | ||||||||||
| Author: | Klagsbrun, Michael|Shimizu, Akio | ||||||||||
| PMID: | 20664165 | ||||||||||
| 8. | |||||||||||
| Journal: | Mol Cancer. 2010 Oct 15;9:276. | ||||||||||
| Title: | Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation. | ||||||||||
| Author: | Yu, Danny C W|Waby, Jennifer S|Chirakkal, Haridasan|Staton, Carolyn A|Corfe, Bernard M | ||||||||||
| PMID: | 20950431 | ||||||||||
| 9. | |||||||||||
| Journal: | Anticancer Res. 2010 Oct;30(10):4209-17. | ||||||||||
| Title: | Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study). | ||||||||||
| Author: | Zhang, Wu|Azuma, Mizutomo|Lurje, Georg|Gordon, Michael A|Yang, Dongyun|Pohl, Alexandra|Ning, Yan|Bohanes, Pierre|Gerger, Armin|Winder, Thomas|Hollywood, Ellen|Danenberg, Kathleen D|Saltz, Leonard|Lenz, Heinz-Josef | ||||||||||
| PMID: | 21036743 | ||||||||||
| 10. | |||||||||||
| Journal: | Mol Cancer. 2011 Mar 14;10:27. | ||||||||||
| Title: | Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma. | ||||||||||
| Author: | Yu, Danny C W|Bury, Jonathan P|Tiernan, James|Waby, Jennifer S|Staton, Carolyn A|Corfe, Bernard M | ||||||||||
| PMID: | 21401950 | ||||||||||
| 11. | |||||||||||
| Journal: | PLoS One. 2011 Apr 4;6(4):e18306. | ||||||||||
| Title: | NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells. | ||||||||||
| Author: | Savas, Sevtap|Azorsa, David O|Jarjanazi, Hamdi|Ibrahim-Zada, Irada|Gonzales, Irma M|Arora, Shilpi|Henderson, Meredith C|Choi, Yun Hee|Briollais, Laurent|Ozcelik, Hilmi|Tuzmen, Sukru | ||||||||||
| PMID: | 21483694 | ||||||||||
| 12. | |||||||||||
| Journal: | Oncol Rep. 2012 Mar;27(3):685-94. | ||||||||||
| Title: | microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. | ||||||||||
| Author: | Zhang, Yujun|He, Xiangjun|Liu, Yulan|Ye, Yingjiang|Zhang, Hui|He, Peiying|Zhang, Qi|Dong, Lingyi|Liu, Yujing|Dong, Jianqiang | ||||||||||
| PMID: | 22134529 | ||||||||||
| 13. | |||||||||||
| Journal: | J Transl Med. 2012 Dec 24;10:254. | ||||||||||
| Title: | Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo. | ||||||||||
| Author: | Fan, Chung-Wei|Chen, Chun-Yu|Chen, Kuei-Tien|Shen, Chia-Rui|Kuo, Yung-Bin|Chen, Ya-Shan|Chou, Yeh-Pin|Wei, Wei-Shan|Chan, Err-Cheng | ||||||||||
| PMID: | 23259795 | ||||||||||
| 14. | |||||||||||
| Journal: | Br J Cancer. 2013 Nov 26;109(11):2765-73. | ||||||||||
| Title: | Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. | ||||||||||
| Author: | Spencer, S K M|Pommier, A J C|Morgan, S R|Barry, S T|Robertson, J D|Hoff, P M|Jurgensmeier, J M | ||||||||||
| PMID: | 24149180 | ||||||||||
| 15. | |||||||||||
| Journal: | Histopathology. 2013 May;62(6):908-15. | ||||||||||
| Title: | Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer. | ||||||||||
| Author: | Staton, Carolyn A|Koay, Ivan|Wu, Jessie M|Hoh, Leslie|Reed, Malcolm W R|Brown, Nicola J | ||||||||||
| PMID: | 23551578 | ||||||||||
| 16. | |||||||||||
| Journal: | Invest New Drugs. 2014 Aug;32(4):653-60. | ||||||||||
| Title: | A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors. | ||||||||||
| Author: | Weekes, Colin D|Beeram, Muralidhar|Tolcher, Anthony W|Papadopoulos, Kyriakos P|Gore, Lia|Hegde, Priti|Xin, Yan|Yu, Ron|Shih, L Mason|Xiang, Hong|Brachmann, Rainer K|Patnaik, Amita | ||||||||||
| PMID: | 24604265 | ||||||||||
| 17. | |||||||||||
| Journal: | Expert Opin Ther Targets. 2015 Feb;19(2):147-61. | ||||||||||
| Title: | Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases. | ||||||||||
| Author: | Chaudhary, Belal|Elkord, Eyad | ||||||||||
| PMID: | 25351619 | ||||||||||
| 18. | |||||||||||
| Journal: | Front Oncol. 2015 Jun 3;5:125. | ||||||||||
| Title: | Neuropilin-1 as Therapeutic Target for Malignant Melanoma. | ||||||||||
| Author: | Graziani, Grazia|Lacal, Pedro M | ||||||||||
| PMID: | 26090340 | ||||||||||
| 19. | |||||||||||
| Journal: | Cancer Gene Ther. 2016 May;23(5):125-32. | ||||||||||
| Title: | VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans. | ||||||||||
| Author: | Kazemi, M|Carrer, A|Moimas, S|Zandona, L|Bussani, R|Casagranda, B|Palmisano, S|Prelazzi, P|Giacca, M|Zentilin, L|De Manzini, N|Giacca, M|Zacchigna, S | ||||||||||
| PMID: | 27033458 | ||||||||||
| 20. | |||||||||||
| Journal: | Oncotarget. 2016 May 31;7(22):32449-61. | ||||||||||
| Title: | Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting. | ||||||||||
| Author: | Kim, Ji-Young|Han, Ji-Hae|Park, Geon|Seo, Young-Woo|Yun, Cheol-Won|Lee, Byung-Chul|Bae, Jeehyeon|Moon, Ae Ran|Kim, Tae-Hyoung | ||||||||||
| PMID: | 27083053 | ||||||||||
| 21. | |||||||||||
| Journal: | Clin Cancer Res. 2016 Oct 15;22(20):5058-5067. | ||||||||||
| Title: | BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer. | ||||||||||
| Author: | Benson, Al B 3rd|Kiss, Igor|Bridgewater, John|Eskens, Ferry A L M|Sasse, Carolyn|Vossen, Sandra|Chen, Jihong|Van Sant, Chip|Ball, Howard A|Keating, Anne|Krivoshik, Andrew | ||||||||||
| PMID: | 27401244 | ||||||||||
| 22. | |||||||||||
| Journal: | Oncotarget. 2016 Sep 27;7(39):63124-63137. | ||||||||||
| Title: | DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling. | ||||||||||
| Author: | Huang, Shiu-Wen|Lien, Jin-Cherng|Kuo, Sheng-Chu|Huang, Tur-Fu | ||||||||||
| PMID: | 27517319 | ||||||||||
| 23. | |||||||||||
| Journal: | Cell Adh Migr. 2016 Nov;10(6):692-699. | ||||||||||
| Title: | The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems. | ||||||||||
| Author: | Ito, Daisuke|Kumanogoh, Atsushi | ||||||||||
| PMID: | 27736304 | ||||||||||
| 24. | |||||||||||
| Journal: | Mol Carcinog. 2017 Jan;56(1):18-35. | ||||||||||
| Title: | Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression. | ||||||||||
| Author: | Zakraoui, Ons|Marcinkiewicz, Cezary|Aloui, Zohra|Othman, Houcemeddine|Grepin, Renaud|Haoues, Meriam|Essafi, Makram|Srairi-Abid, Najet|Gasmi, Ammar|Karoui, Habib|Pages, Gilles|Essafi-Benkhadir, Khadija | ||||||||||
| PMID: | 26824338 | ||||||||||
| 25. | |||||||||||
| Journal: | Drug Des Devel Ther. 2017 Jan 11;11:177-184. | ||||||||||
| Title: | Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies. | ||||||||||
| Author: | Francoso, Alex|Simioni, Patricia Ucelli | ||||||||||
| PMID: | 28138221 | ||||||||||
| 26. | |||||||||||
| Journal: | Int J Oncol. 2018 Apr;52(4):1350-1362. | ||||||||||
| Title: | VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells. | ||||||||||
| Author: | Tomida, Chisato|Yamagishi, Naoko|Nagano, Hikaru|Uchida, Takayuki|Ohno, Ayako|Hirasaka, Katsuya|Nikawa, Takeshi|Teshima-Kondo, Shigetada | ||||||||||
| PMID: | 29532881 | ||||||||||
| 27. | |||||||||||
| Journal: | Nucl Med Biol. 2018 Jul - Aug;62-63:54-62. | ||||||||||
| Title: | (99m)Tc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging. | ||||||||||
| Author: | Rezazadeh, Farzaneh|Sadeghzadeh, Nourollah|Abedi, Seyed Mohammad|Abediankenari, Saeid | ||||||||||
| PMID: | 29885559 | ||||||||||
| 28. | |||||||||||
| Journal: | Clin Chim Acta. 2018 Oct;485:158-165. | ||||||||||
| Title: | Neuropilin 1 (NRP1) is a novel tumor marker in hepatocellular carcinoma. | ||||||||||
| Author: | Lin, Jiafei|Zhang, Yingwei|Wu, Jiemin|Li, Li|Chen, Ning|Ni, Peihua|Song, Lihua|Liu, Xiangfan | ||||||||||
| PMID: | 29966621 | ||||||||||
| 29. | |||||||||||
| Journal: | Stroke. 2018 Nov;49(11):2733-2742. | ||||||||||
| Title: | Cancer Exacerbates Ischemic Brain Injury Via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor. | ||||||||||
| Author: | Wang, Long|Zhou, Yuxi|Yin, Jiemin|Gan, Yu|Wang, Xin|Wen, Daxiang|Thomson, Angus W|Hu, Xiaoming|Yang, Liqun|Stetler, R Anne|Li, Peiying|Yu, Weifeng | ||||||||||
| PMID: | 30355201 | ||||||||||